earnings
confidence high
sentiment positive
materiality 0.85
McKesson Q2 FY2025 revenue $93.7B (+21%), adj. EPS $7.07 (+13%), raises FY25 adj. EPS guidance
MCKESSON CORP
2025-Q2 EPS
reported $8.89
vs consensus $8.23
▲ beat
(+8.0%)
- Revenue $93.7B, +21% YoY; GAAP diluted EPS $1.87 (down 62% vs $4.92); adjusted EPS $7.07 (+13%).
- Raises FY2025 adjusted EPS guidance to $32.40-$33.00 from $31.75-$32.55, implying 18-20% growth.
- Announced agreement to acquire controlling interest in Florida Cancer Specialists & Research Institute's Core Ventures.
- Announced agreement to sell Canada-based Rexall and Well.ca retail businesses.